Notice of Intent to Publish a Funding Opportunity Announcement for Building Partnerships and Broadening Perspectives to Advance Ethical, Legal and Social Implications (ELSI) Research (UM1), Clinical Trial Optional
ID: 353687Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353687
Timeline
    Description

    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the "Building Partnerships and Broadening Perspectives to Advance Ethical, Legal and Social Implications (ELSI) Research (UM1)" grant. This grant aims to advance scholarship on the ethical, legal, and social implications of advances in human genetics or genomics. It also aims to enhance ELSI research teams, build ELSI research capacity, and broaden the ELSI workforce. The NOFO is expected to be published in the summer of 2024, with an application due date in the fall of 2024. The grant will utilize the UM1 activity code, which is a Research Project with Complex Structure, Cooperative Agreement, Clinical Trial Optional. The estimated total program funding is $2,600,000, and it is expected to award 4 grants. The estimated award date and project start date are both September 1, 2025.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program," aimed at fostering transdisciplinary ELSI research among underrepresented domestic organizations. The program seeks applications from entities that have received less than $30 million in NIH funding annually over the past three years, focusing on enhancing community engagement, building research capacity, and developing a diverse workforce in the field of genomics. With an anticipated funding amount of approximately $4.8 million for up to four awards, projects can last up to five years, and applicants must adhere to specific guidelines and deadlines, with submissions due by August 2, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)" grant, aimed at investigating the ethical, legal, and social implications arising from human genetics and genomics research. Applicants are encouraged to utilize diverse multidisciplinary approaches, including empirical qualitative and quantitative methods, and must include a "Plan for Enhancing Diverse Perspectives" to promote inclusivity within research teams. This funding opportunity is critical for addressing complex issues related to genomic advancements, such as equity in healthcare and the implications of genomic data sharing. Applications will be accepted from January 2025 until November 18, 2026, with a maximum project period of five years, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)" to support research that investigates the ethical, legal, and social implications of human genetics and genomics. This grant encourages applications that utilize a variety of research methods, including empirical qualitative and quantitative approaches, to address significant ELSI issues arising from advancements in genomic technologies. The initiative aims to foster community engagement, particularly with historically underserved populations in genomic research, reflecting a commitment to ethical considerations in scientific progress. Grants of up to $275,000 are available for projects spanning two to three years, with application deadlines starting January 19, 2024, and funding decisions expected by July 2024. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Exploratory/Developmental Research Grants (R21) focused on the Ethical, Legal, and Social Implications (ELSI) of human genetics and genomics. This initiative invites applications that utilize various methodologies, including qualitative and quantitative research, to explore ELSI issues and foster interdisciplinary collaboration while informing policy on equitable genomic research applications across diverse populations. The program aims to address critical areas such as cancer disparities and community engagement in genomics, recognizing the transformative potential of genomics in healthcare while assessing ethical and social challenges, particularly for underrepresented communities. Applicants may request up to $275,000 for projects lasting up to three years, with applications due between January 20, 2025, and November 19, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03), aimed at funding small-scale research projects that investigate the ethical, legal, and social dimensions of human genetics and genomics. This funding opportunity encourages innovative research that addresses the complexities and emerging questions associated with genomic advancements, particularly focusing on diverse populations and potential inequities in access and benefits. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government agencies, with funding of up to $50,000 available per year for a maximum of two years. Applications will be accepted starting January 19, 2024, with various submission deadlines through 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Ethical, Legal, and Social Implications (ELSI) Small Research Grant (R03), aimed at supporting research on the implications of human genetics and genomics. This grant encourages applications that explore ELSI issues through various methodologies, including conceptual analyses and empirical studies, with an emphasis on community engagement and stakeholder involvement. The initiative seeks to enhance understanding of the societal impacts of genomic research, promote equitable healthcare access, and address disparities in genomic applications. Eligible applicants can receive up to $50,000 annually for a maximum of two years, with the application deadline set for November 16, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-370.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the "Supporting Talented Early Career Researchers in Genomics" program, utilizing the R01 activity code. This initiative aims to provide financial support to early career researchers in the field of genomics, facilitating the development of innovative projects that contribute to the understanding of human genetics. The estimated total program funding is $2 million, with an award ceiling of $400,000 per project, and the application period is expected to open on December 18, 2024, with a closing date of February 28, 2025. Interested applicants should prepare their proposals in advance, as the estimated award date is set for December 31, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for Environmental Health Disparities Centers (P50)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Environmental Health Disparities Centers (P50) program, aimed at addressing environmental health disparities and promoting environmental justice. This initiative will focus on research and training that targets NIH-designated health disparities populations, particularly racial and ethnic minorities, socioeconomically disadvantaged groups, and individuals from rural or under-resourced areas, in alignment with recent executive orders on environmental justice. The anticipated NOFO is expected to be released in Summer 2024, with applications due in Fall 2024, and the estimated award date is set for July 1, 2025. Interested applicants should prepare to develop responsive applications as further details will be provided in the forthcoming announcement.
    Notice of Intent to Publish a Notice of Funding Opportunity for Coordination Center for the Alzheimer�s Disease Sequencing Project Consortium (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Coordination Center for the Alzheimer’s Disease Sequencing Project Consortium, aimed at advancing research in Alzheimer's disease genetics. This initiative, which follows the approval of the concept by the National Advisory Council on Aging, will invite applications under an open competition framework, expanding eligibility for potential applicants. The funding opportunity is critical for fostering collaborations and innovative projects in the field of health, with an estimated total program funding of $1.6 million and a maximum award ceiling of $1 million for the selected applicant. The NOFO is expected to be published in November 2024, with applications due by February 14, 2025, and awards anticipated to be made by September 1, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRI�s Diversity Action Plan (R25 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) aimed at transforming the National Human Genome Research Institute's (NHGRI) Diversity Action Plan (R25 Clinical Trials Not Allowed) to enhance workforce diversity in genomics. This initiative seeks to support the training, employment, and retention of individuals from underrepresented backgrounds in the biomedical workforce, aligning with NHGRI's strategic objectives to foster diverse scientific teams that drive innovation and creativity. The FOA is expected to be published in Summer 2023, with applications due in Early 2024, and the estimated award date is set for September 9, 2024. For further inquiries, interested parties can contact Dr. Lucia A. Hindorff at hindorffl@mail.nih.gov.